Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization

被引:35
|
作者
Suphaphiphat, P
Thitithanyanont, A
Paca-Uccaralertkun, S
Essex, M
Lee, TH
机构
[1] Harvard Univ, Sch Med, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[2] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand
关键词
D O I
10.1128/JVI.77.6.3832-3837.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The V3 loop and the bridging sheet domain of human immunodeficiency virus type 1 (HIV-1) subtype B envelope glycoprotein gp120 have been implicated in CCR5 coreceptor utilization. In this study, mutant envelope glycoproteins of a subtype C isolate containing substitutions in the V3 or C4 region were generated to determine which are required for efficient CCR5-dependent cell fusion and viral entry. We found that the V3 crown and C4 residues are relatively dispensable for cell-cell fusion, although some residues may be involved in the regulation of early postentry steps in viral replication. In contrast, seven highly conserved residues located in the V3 stem are critical for CCR5 utilization, which can explain the apparent paradox that the functional convergence in CCR5 usage by genetically divergent HIV-1 strains involves a variable region. The finding that C4 residues do not have a critical role may appear to contradict the current model that bridging sheet residues are involved in the gp120-CCR5 interaction. However, a plausible interpretation is that these C4 residues may have a distinct role in the binding and fusion steps of the gp120-CCR5 interaction.
引用
收藏
页码:3832 / 3837
页数:6
相关论文
共 50 条
  • [21] Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5
    Olson, WC
    Rabut, GEE
    Nagashima, KA
    Tran, DNH
    Anselma, DJ
    Monard, SP
    Segal, JP
    Thompson, DAD
    Kajumo, F
    Guo, Y
    Moore, JP
    Maddon, PJ
    Dragic, T
    JOURNAL OF VIROLOGY, 1999, 73 (05) : 4145 - 4155
  • [22] V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1
    Chan, SY
    Speck, RF
    Power, C
    Gaffen, SL
    Chesebro, B
    Goldsmith, MA
    JOURNAL OF VIROLOGY, 1999, 73 (03) : 2350 - 2358
  • [23] CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120
    Wang, WK
    Dudek, T
    Zhao, YJ
    Brumblay, HG
    Essex, M
    Lee, TH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (10) : 5740 - 5745
  • [24] Small amino acid changes in the V3 loop of human immunodeficiency virus type 2 determines the coreceptor usage for CXCR4 and CCR5
    Isaka, Y
    Sato, A
    Miki, S
    Kawauchi, S
    Sakaida, H
    Hori, T
    Uchiyama, T
    Adachi, A
    Hayami, M
    Fujiwara, T
    Yoshie, O
    VIROLOGY, 1999, 264 (01) : 237 - 243
  • [25] AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION
    BACK, NKT
    SMIT, L
    DEJONG, JJ
    KEULEN, W
    SCHUTTEN, M
    GOUDSMIT, J
    TERSMETTE, M
    VIROLOGY, 1994, 199 (02) : 431 - 438
  • [26] SIGNATURE MUTATIONS IN V3 AND BRIDGING SHEET DOMAIN OF HIV-1 GP120 HIV-1 ARE SPECIFICALLY ASSOCIATED WITH DUAL TROPISM AND MODULATE THE INTERACTION WITH CCR5 N-TERMINUS
    Alteri, C.
    Artese, A.
    Zhang, J. M.
    Mercurio, F.
    Costa, G.
    Stazi, F.
    Fabeni, L.
    Bertoli, A.
    Forbici, F.
    Salpini, R.
    Dimonte, S.
    Alcaro, S.
    Ceccherini-Silberstein, F.
    Perno, C. F.
    Svicher, V.
    INFECTION, 2011, 39 : S39 - S39
  • [27] PRESENTATION OF NATIVE EPITOPES IN THE V1/V2 AND V3 REGIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 BY FUSION GLYCOPROTEINS CONTAINING ISOLATED GP120 DOMAINS
    KAYMAN, SC
    WU, ZW
    REVESZ, K
    CHEN, HC
    KOPELMAN, R
    PINTER, A
    JOURNAL OF VIROLOGY, 1994, 68 (01) : 400 - 410
  • [28] Short Communication: HIV-1 Variants That Use Mouse CCR5 Reveal Critical Interactions of gp120's V3 Crown with CCR5 Extracellular Loop 1
    Platt, Emily J.
    Durnin, James P.
    Kabat, David
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2015, 31 (10) : 992 - 998
  • [29] Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop
    Hoffman, NG
    Seillier-Moiseiwitsch, F
    Ahn, J
    Walker, JM
    Swanstrom, R
    JOURNAL OF VIROLOGY, 2002, 76 (08) : 3852 - 3864
  • [30] Resistance of a human immunodeficiency virus type 1 isolate to a small molecule CCR5 inhibitor can involve sequence changes in both gp120 and gp41
    Anastasopoulou, Cleo G.
    Ketas, Thomas J.
    Depetris, Rafael S.
    Thomas, Antonia M.
    Klasse, Per Johan
    Moore, John P.
    VIROLOGY, 2011, 413 (01) : 47 - 59